UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
55 hedge funds and large institutions have $258M invested in Unity Biotechnology in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+13
Holders Change %
+30.95%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
21
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$30.1M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$11.8M |
| 3 |
3
Capital World Investors
Los Angeles,
California
|
$23.8M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$6.53M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$62.6M |
Top Sellers
| 1 |
NTC
1
NF Trinity Capital
Central,
Hong Kong
|
$0 |
| 2 |
AG
2
Artal Group
Luxembourg
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$1.25M |
| 4 |
4
Millennium Management
New York
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$0 |
